We are developing a new treatment for ischemic stroke using a modified version of a natural anticoagulant called ADAMTS13. Existing stroke therapies are limited by a short treatment window and can carry serious risks. This new approach aims to safely extend the time patients can receive treatment, increasing access, especially for those in rural or […]
Read More